Tag : Extended

Pharma / Biotech

Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B.

Newsemia
Related Articles Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B. J Thromb Haemost....
Cardiology

Effects of Extended Lower Extremity Cooling Following Zone 3 REBOA in a Porcine Hemorrhage Model.

Newsemia
Related Articles Effects of Extended Lower Extremity Cooling Following Zone 3 REBOA in a Porcine Hemorrhage Model. Mil Med. 2020 Jan 07;185(Supplement_1):42-49 Authors: Kashtan HW,...
Latest News

Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS

Newsemia
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology presented interim results of its CONTROL Trial on Dec. 13 at the 2019 San Antonio Breast Cancer Symposium. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy